Trial intelligence / Profile preview

SVV-guided Fluid Management in Craniotomy

NCT02113358Unknown

Sponsor
National Taiwan University Hospital
Start
Apr 2014
Primary completion
May 2015
Modality
Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
Countries
1
01

Overview

Randomised, single-blind trial of Volulyte in Supratentorial brain tumor (STBT), sponsored by National Taiwan University Hospital. Primary endpoint: S100B protein. Status: unknown.

02

Drugs

Volulyte
03

Conditions

Supratentorial brain tumor (STBT)

Beyond the preview

Go deeper on NCT02113358.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02113358.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call